» Articles » PMID: 11090147

Herpes Simplex Virus Type 1 ICP4 Promotes Transcription Preinitiation Complex Formation by Enhancing the Binding of TFIID to DNA

Overview
Journal J Virol
Date 2000 Nov 23
PMID 11090147
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Infected-cell polypeptide 4 (ICP4) of herpes simplex virus type 1 (HSV-1) activates the expression of many HSV genes during infection. It functions along with the cellular general transcription factors to increase the transcription rates of genes. In this study, an HSV late promoter consisting of only a TATA box and an INR element was immobilized on a magnetic resin and incubated with nuclear extracts or purified TFIID in the presence and absence of ICP4. Analysis of the complexes formed on these promoters revealed that ICP4 increased the formation of transcription preinitiation complexes (PICs) in a TATA box-dependent manner, as determined by the presence of ICP4, TFIID, TFIIB, and polymerase II on the promoter. With both nuclear extract and purified TFIID, it was determined that ICP4 helped TFIID bind to the promoter and the TATA box. These observations differed from those for the activator Gal4-VP16. As previously observed by others, Gal4-VP16 also increased the formation of PICs without helping TFIID bind to the promoter, suggesting that ICP4 and VP16 differ in their mechanism of activation and that ICP4 functions to facilitate PIC formation at an earlier step in the formation of PICs. We also observed that the DNA binding activity of ICP4 was not sufficient to help TFIID bind to the promoter and that the region of ICP4 that was responsible for this activity is located between residues 30 and 274. Taken together these results demonstrate that a specific region of ICP4 helps TFIID bind to the TATA box and that this in turn facilitates the formation of transcription PICs.

Citing Articles

Sp1 facilitates continued HSV-1 gene expression in the absence of key viral transactivators.

Sodroski C, Oh H, Chou S, Knipe D mBio. 2024; 15(3):e0347923.

PMID: 38349188 PMC: 10936440. DOI: 10.1128/mbio.03479-23.


A CRISPR-based rapid DNA repositioning strategy and the early intranuclear life of HSV-1.

Xiang J, Fan C, Dong H, Ma Y, Xu P Elife. 2023; 12.

PMID: 37702383 PMC: 10522339. DOI: 10.7554/eLife.85412.


Herpes Simplex Virus 1 (HSV-1) Infected Cell Protein 0 (ICP0) Targets of Ubiquitination during Productive Infection of Primary Adult Sensory Neurons.

Harrell T, Davido D, Bertke A Int J Mol Sci. 2023; 24(3).

PMID: 36769256 PMC: 9917815. DOI: 10.3390/ijms24032931.


Full Viral Genome Sequencing and Phylogenomic Analysis of Feline Herpesvirus Type 1 (FHV-1) in Cheetahs ().

Marino M, Mironovich M, Ineck N, Citino S, Emerson J, Maggs D Viruses. 2021; 13(11).

PMID: 34835113 PMC: 8625435. DOI: 10.3390/v13112307.


Advancing Our Understanding of Corneal Herpes Simplex Virus-1 Immune Evasion Mechanisms and Future Therapeutics.

Greenan E, Gallagher S, Khalil R, Murphy C, Ni Gabhann-Dromgoole J Viruses. 2021; 13(9).

PMID: 34578437 PMC: 8473450. DOI: 10.3390/v13091856.


References
1.
Arias J, Dynan W . Promoter-dependent transcription by RNA polymerase II using immobilized enzyme complexes. J Biol Chem. 1989; 264(6):3223-9. View

2.
Carrozza M, Deluca N . The high mobility group protein 1 is a coactivator of herpes simplex virus ICP4 in vitro. J Virol. 1998; 72(8):6752-7. PMC: 109883. DOI: 10.1128/JVI.72.8.6752-6757.1998. View

3.
Buratowski S, Hahn S, Guarente L, Sharp P . Five intermediate complexes in transcription initiation by RNA polymerase II. Cell. 1989; 56(4):549-61. DOI: 10.1016/0092-8674(89)90578-3. View

4.
Shepard A, Imbalzano A, DeLuca N . Separation of primary structural components conferring autoregulation, transactivation, and DNA-binding properties to the herpes simplex virus transcriptional regulatory protein ICP4. J Virol. 1989; 63(9):3714-28. PMC: 250963. DOI: 10.1128/JVI.63.9.3714-3728.1989. View

5.
Chasman D, LEATHERWOOD J, Carey M, Ptashne M, Kornberg R . Activation of yeast polymerase II transcription by herpesvirus VP16 and GAL4 derivatives in vitro. Mol Cell Biol. 1989; 9(11):4746-9. PMC: 363622. DOI: 10.1128/mcb.9.11.4746-4749.1989. View